Simon Grinstead - DPhil Evidence Based Health Care Research Candidate
Simon Grinstead
BSc (Hons) MSc (Oxon)
DPhil Evidence Based Health Care Research Candidate
This research focuses on the post-acquisition outcomes of disruptive medical innovation and policy implications for anti-trust regulation.
Research summary
We investigate why some innovative medical technology products fail to enter the market after being acquired by large incumbent healthcare companies. Little empirical evidence exists to reveal the details surrounding these events. This research aims to understand the conduct, behaviour, reasons, motives and any strategic intent by corporates involved in terminating acquired medical technology innovation. Potential benefits include identifying reasons for failure and proposing ways to increase the number of medical innovations reaching patients. Insights for improving outcomes may emerge that benefit industry and regulatory bodies. Improving the processes may benefit healthcare practitioners and patients by enhancing access to superior medical innovations. The mixed methods used to investigate industry activity, through data analysis and from first-hand accounts, could benefit other academics who wish to focus on this field of research.
Supervisors: Professor Jonathan Michie & Professor Sue Dopson
